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The objective of this study was to evaluate the quality and comparability of published literature, and
to summarize the effect of prostaglandin F2α (PGF2α) for the treatment of endometritis. It has been
postulated that there is a dearth of high-level evidence-based research results in veterinary medicine.
Also, there is a marked variation in the quality of studies in veterinary and animal science. Post-
partum uterine infections occur commonly in dairy cattle and are reported to have a negative impact
on reproductive performance. A comprehensive literature search was conducted utilizing online
databases revealing a total of 2723 references. After applying specific exclusion criteria, a total of 68
trials were eligible for further analysis. These articles were evaluated utilizing specific parameters
listed in an evaluation form such as randomization and the involvement of control groups. The
analysis revealed that more than half of the trials (51·5%) were at least 20 years old. Furthermore, we
found that about one third (36·8%) of all trials were controlled and randomized, while 3 of those
(4·4%) were also blinded. Of those trials which calculated a calving-to-conception interval (n=30),
50% of the authors claimed an improvement, whichwas statistically significant in 23·3% of the cases.
We conclude that there is a wide discrepancy between research results investigating the efficacy of
PGF2α.
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The decision-making process of practising veterinarians as
well as farm personnel and animal scientists should be based
on objective information (Holmes & Cockcroft, 2004).
Therefore the implementation of evidence-based medicine
becomes increasingly important. Sackett et al. (1996) defined
evidence-based medicine as the conscientious, explicit
and judicious use of the best external evidence currently
available, for the purpose of making decisions concerning
the medical care of individual patients. The term ‘evidence’
demonstrates the degree of certainty with which the results
of a study reliably represent reality (Arlt & Heuwieser, 2005).
However, Holmes & Cockcroft (2004) have postulated
that there is a dearth of methodologically performed,
rigorous, large-scale clinical studies in veterinary medicine
resulting in a lack of research results of high evidence. This
hypothesis has been supported by several authors (Mair &
Cohen, 2003; Arlt et al. 2010) who demonstrated that in
veterinary medicine the increase of knowledge is mainly
based on reviewing field reports rather than randomized,
controlled clinical studies. Nevertheless, researchers seem
to have become increasingly aware of this problem. Not only
did several authors develop some kind of guidelines
concerning the question of how to conduct high-quality
studies or meta-analyses (e.g. Lean et al. 2009). Also, many
very well-conducted studies eligible for performing meta-
analyses have been published during recent years (Rabiee
et al. 2005; Lean et al. 2006). Nevertheless, randomized,
controlled, double-blinded studies are the gold standard
with regard to the evaluation of a given treatment (Kastelic,
2006). The quality of a certain study depends on its design,
its clinical relevance, the analysis of the study results, and the
quality and comprehensiveness of the reporting (Arlt &
Heuwieser, 2005). Four stages of evidence have been
suggested to categorize studies with respect to their quality
(Bassler & Antes, 2000). Stage I represents the highest level of
evidence and refers to meta-analyses of randomized,
controlled studies or evidence gained from at least
one randomized, controlled study. Well-designed, con-
trolled studies without randomization and well-designed,
quasi-experimental studies generate evidence of stage II.*For correspondence; e-mail: w.heuwieser@fu-berlin.de
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Evidence being categorized as stage III is obtained through
well-designed, descriptive studies that are not experimental.
Finally, the lowest stage of evidence (stage IV) covers
opinions of experts, results presented at scientific meetings
as well as clinical experience of accredited authorities. In
order to improve the quality of publications, scientists
developed checklists containing important aspects for
conducting trials. For instance, the CONSORT and the
PRISMA statements aim to improve the reporting of
randomized clinical trials, as well as systematic reviews
andmeta-analyses. The REFLECT statement is a modification
of the CONSORT statement for veterinary science as
livestock and food safety. Besides the lack of high-evidence
studies, there is a marked variation in the quality of studies in
veterinary science, resulting in insufficient comparability of
the various trials (Cockcroft & Holmes, 2003).
Clinical endometritis in cattle is defined as the presence of
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vagina 21 d or more post partum, or mucopurulent
(approximately 50% pus, 50% mucus) discharge detectable
in the vagina after 26 d post partum, (Sheldon et al. 2006).
Most recently, following a study conducted by Runciman
et al. (2008) which aimed to evaluate the role of vaginoscopy
in predicting a reduction in reproductive performance
parameters associated with a positive discharge detected
by vaginoscopy, cytological endometritis diagnosed with a
cytobrush and purulent vaginal discharges diagnosed by
Metricheck device have been described as distinct manifes-
tations of uterine inflammation (Dubuc et al. 2010b). The
prevalence of post-partum uterine infections (up to 57·7%)
(Sheldon, 2009) and the resulting opportunity costs (de-
creased fertility, increased culling) underline the importance
of this disease (Plaizier et al. 1998; LeBlanc et al. 2002a;
LeBlanc, 2008).
There is a wealth of information on the treatment of
endometritis and this subject has been reviewed extensively
by several authors (Gilbert & Schwark, 1992; Olson, 1996;
Azawi, 2008). However, the treatment of endometritis is still
an issue of considerable controversy (Arlt et al. 2009; Dubuc
et al. 2011). This may be due to the wide variety of therapies
available for endometritis, including systemic or local
antibiotics, prostaglandin F2α (PGF2α) and oestradiol.
Numerous studies have been conducted to evaluate the
effect of a treatment with PGF2α or its analogues within 40 d
of calving on reproductive performance of dairy cows. It is
noteworthy that there is a wide disparity between the results
(Burton & Lean, 1995). Young et al. (1984), for instance,
reported a significant improvement in the first service
conception rates of cows given PGF2α, whereas a study
conducted by Macmillan et al. (1987) and including 1813
cows could not support these findings.
To shed some light on this issue, the overall objective of
this study was to evaluate the quality and comparability of
published literature and to summarize the effect of PGF2α for
the treatment of endometritis. Specifically we set out to test
two hypotheses: (1) studies published are diverse in respect
to relevant quality criteria such as control groups, blinding,
randomization, and sample size and (2) the majority of trials
reveal an improvement of the reproductive performance
through the application of PGF2α to cows with endometritis.
Materials and Methods
A comprehensive literature search was conducted on 4
August 2010 utilizing the search engine Vetseek (http://
www.vetseek.info), databases Pubmed (http://www.
pubmed.gov), Medline (http://www.medline.de), and
Animal Production (http://www.ovid.com/site/catalog/
DataBase/22.jsp) to identify literature related to the treatment
of endometritis with prostaglandin in dairy cattle. The
subject headings ‘endometritis AND cattle’, ‘endometritis
AND cattle AND prostaglandin’ were used to include all
articles written in English or German addressing the
treatment of bovine endometritis with PGF2α. In addition, a
systematic review of citations in the retrieved papers was
carried out. We defined specific exclusion criteria to only
include studies that focus on chronic endometritis, i.e.
presence of a purulent (>50% pus) uterine discharge
detectable in the vagina 21 d or more post partum
(Sheldon et al. 2006). Furthermore, we excluded studies in
which the animals received concomitant treatments with
medications other than PGF2α. Also, book chapters, case
studies, review articles and abstracts were excluded.
Furthermore, publications describing aetiological, epide-
miological, microbiological or nutritional results, clinical
symptoms or diagnostic procedures were rejected. Articles
not meeting the inclusion criteria, owing to wrong indexa-
tion, and those not obtainable through the internet,
bibliographies or inter-lending services were excluded as
well. If multiple publications were retrieved describing the
same trial, those containing the least information were
regarded as doublets and excluded. Retrieval and manage-
ment of references was performed with Endnote (Version X3
for Windows, Thomson Reuters, New York, NY, USA).
The remaining publications were evaluated according to
various evidence parameters utilizing an evaluation form
developed by Arlt (2010) and recently validated by Simoneit
et al. (2011). Relevant criteria of the study design such as
sample size, the involvement of control groups, either
untreated, placebo-treated or treated with a drug other
than PGF2α, blinding and randomization were considered.
Furthermore, type and definition of endometritis, diagnostic
methods, the drug and dosage applied, route of application,
Table 2. Relevant criteria of 68 trials studying the efficacy of PGF2α

















41990 53·1 45·0 56·3 51·5
1991–2000 18·8 20·0 25·0 20·6




84·4 75·0 62·5 76·5
Number of total endometritis cases
450 9·4 15·0 31·3 16·2
51–150 15·6 45·0 25·0 26·5
>150 71·9 40·0 43·8 55·9
>200 43·8 35·0 25·0 36·8
Not specified 3·1 0·0 0·0 1·5
Endometritic animals exclusively treated with PGF2α
450 12·5 35·0 37·5 25·0
51–150 48·0 32·4 37·5 48·5
>150 28·1 10·0 25·0 22·1
>200 21·9 10·0 6·3 14·7
Not specified 9·4 0·0 0·0 4·4
†According to Sheldon et al. (2006)
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number of treatments, treatment time relative to calving, and
reproductive performance parameters, i.e. calving to first
service interval, calving to conception interval and con-
ception rate, were documented in a spreadsheet. Descriptive
statistics were compiled using SPSS for Windows (Version
18.0; SPSS Inc., Munich, Germany).
Results
In total, 4393 publications were retrieved (Vetseek, 2369;
Pubmed, 570; Medline, 565; Animal Production, 889). After
excluding doublets (n=1670), 2723 publications remained.
According to the exclusion criteria, 2662 indexed articles
had to be excluded resulting in 61 remaining publications
which comprised 63 individual trials. Because 4 articles
were retrieved through search by hand, a total of 65
publications, comprising 68 trials, met the inclusion criteria
and were suitable for further analysis (Table 1).
According to Sheldon’s (2006) definition of chronic
endometritis, diagnosis had to be conducted later than
20 d post partum. However, several studies complied only
partly with this time period (n=20), whereas others did not
provide an exact time of diagnosis at all (n=16). To account
for this variation, we decided to subdivide the studies
according to their date of diagnosis.
More than half of all 68 trials (51·5%) were older than
20 years (Table 2). Trials that did not give a specific definition
of endometritis made up 23·5% of all trials analysed. We
found a sample size smaller than 50 in 16·2% of all trials and
about one-third of the studies (36·8%) had included more
than 200 animals. Overall, 70·6% of all trials included a
control group (Table 3). Of those, 60·3% had a positive (a
drug other than PGF2α), 22·1% an untreated, and 5·9% a
placebo-treated control group. In 41·2% of all trials, the
authors stated that allocation to treatment and control group
had been conducted in a random manner. In 11·8% of all
studies randomization was computerized, whereas 16·2%
allocated the cows enrolled in an alternating order or with
the help of ear-tag numbers, and 13·2% did not offer any
details concerning the mode of randomization. Our
investigation revealed that 38·2% of all trials were controlled
and randomized. In this context, control groups were either
untreated, placebo-treated or treated with a drug other than
PGF2α. Trials were considered as randomized if the animals
had reportedly been allocated to the various groups in
random manner, i.e. by chance. Only 3 of those articles
(4·4%) were also blinded.
Among the 68 trials, a wide variety of methods to
diagnose the disease in question could be identified
(Table 4). However, 13·2% did not specify the particular
method used.










No exact date of
diagnosis given
(n=16)
Control group 75·0 70·0 63·0 70·6
Untreated 18·8 25·0 25·0 22·1
Placebo 6·3 5·0 6·3 5·9
Reference group 65·6 60·0 50·0 60·3
Blinding
Yes 9·4 0·0 6·3 5·9
No 81·3 100·0 93·8 89·7
Not specified 9·4 0·0 0·0 4·4
Randomization
Yes 40·6 45·0 37·5 41·2
Computerized 9·4 20·0 6·3 11·8
By ear tag number 18·8 5·0 6·3 10·3
Alternate allocation 6·3 5·0 6·3 5·9
Not specified 6·3 15·0 25·0 13·2
No 50,0 50·0 37·5 47·1
Not specified 9·4 5·0 25·0 11·8
Randomization+control group 37·5 40·0 37·5 38·2
Computerized 9·4 20·0 6·3 11·8
By ear tag number 15·6 0·0 0·0 7·4
Alternate allocation 6·3 5·0 6·3 5·9
Not specified 6·3 15·0 18·8 13·2
Randomization, control group+blinding 6·3 0·0 6·3 4·4
†According to Sheldon et al. (2006)
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Concerning reproductive performance parameters, 19·1%
of the studies provided a concise definition. By taking a
closer look at the single parameters, it becomes obvious
that the conclusions of the authors concerning an improve-
ment are only partly proved as statistically significant
(Table 5).
Similar observations were made when assessing repro-
ductive performance parameters examined in randomized
and controlled trials as well as randomized, controlled, and
blinded trials (Table 6).
Considering high-level evidence studies for which a
conception rate was calculated (n=16), 7, 7 and 2 articles
respectively revealed a positive, none or a negative effect
(Table 7). Of those 7 articles revealing a positive effect, only
3 showed statistical significance. Twenty-two of thirty
articles which were attributed to a moderate or high
evidence level did not demonstrate a statistically significant
effect of a PGF2α treatment. Six low-quality papers
concluded a positive effect without statistical validation.
Discussion
The checklists introduced may also be useful for critical
appraisal of published reviews, but they are not explicitly
designed as quality assessment instruments to determine the
quality of articles (Simoneit et al. 2011). Hence, for our
study, we applied the evaluation form designed by Arlt et al.
(2010).
One might question whether studies older than 20 years
should be included in such systematic literature assessment
since the dairy industry has changed considerably





After 21 d p.p.†
(n=32)
Before or after 21
d p.p.
(n=20)




External inspection‡ 3·1 5·0 0·0 2·9
Rectal palpation 34·4 0·0 0·0 16·2
Vaginoscopy 3·1 0·0 0·0 1·5
External inspection‡+rectal Palpation 21·9 30·0 12·5 22·1
Rectal palpation+vaginoscopy 21·9 30·0 12·5 22·1
External inspection‡, rectal
palpation+vaginoscopy
6·3 20·0 6·3 10·3
Other 0·0 0·0 12·5 2·9
Imprecise information 3·1 10·0 18·8 8·8
Not specified 6·3 5·9 5·0 13·2
Multiple treatment(s)
Yes 34·4 10·0 6·3 20·6
No 15·6 30·0 37·5 25·0
If necessary/partly 34·4 35·0 12·5 29·4
Not specified 18·8 25·0 37·5 25·0
Route of administration
Intramuscular 59·4 75·0 62·5 64·7
Subcutaneous 3·1 0·0 0·0 1·5
Diverse routes used 9·4 5·0 37·5 5·9
Not specified 18·8 28·1 20·0 27·9
Definition of reproductive performance
parameters given
25·0 25·0 0·0 19·1
†According to Sheldon et al. (2006)
‡External inspection of the vulvar region
Table 5. Reproductive performance parameters described in 68


















Conception rate (n=48) 35·4 12·5 8·3
†According to the authors’ conclusion
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particularly in respect to housing, feeding, and management
(LeBlanc et al. 2006). In the last two decades milk yield has
increased by 39·2% (1990: 6705 kg/cow; 2009: 9333 kg/
cow) (Blayney, 2002; USDA, 2010) and 45·2% (1990:
4857 kg/cow; 2010: 7050 kg/cow) (BMELV, 1992; ADR,
2010) in the United States and Germany, respectively. Thus,
it can be questioned whether trials conducted more than 20
years ago support adequate evidence for specific rec-
ommendations in livestock health care today. On the other
side, these studies provided observational evidence for the
efficacy of PGF2α and were a relevant component of the
development of the current best-practice standard.
The majority of the trials evaluated had insufficient detail
of study design. In 16·2% of the trials the total sample size
was smaller than 50, and only 36·8% had included more
than 200 animals. More important than the absolute number
of animals included, is the question whether the sample size
of each groupwas large enough to test the proposed research
hypothesis. None of the authors, however, mentioned a
calculation of sample size for the study. Therefore, a final
evaluation of the adequacy of the sample size is not possible.
Our investigation revealed that only about one-third of all
trials was controlled and randomized. Themean sample size
of those trials was 165·3±99. Untreated or placebo-treated
control groups were included in only 28% of all trials. An
overall shortage of randomized, controlled trials in veter-
inary medicine was also described by Kastelic (2006).
This deficiency might be due to the high costs involved
and ethical issues related to leaving diseased animals
untreated.
A computer-generated random allocation of animals to
treatment groups was implemented in only about a fourth of
the randomized trials. The other trials allocated their animals
according to ear-tag numbers or in an alternating order or did
not offer any details concerning the mode of randomization
at all.
According to Lund et al. (1994), a truly random allocation
scheme (assured by computer or random number table)
implies a predetermined probability for every potential study
subject for assignment to a treatment group. In contrast,
systematic assignments, e.g. based on days of the week, are
not recommended because they are vulnerable to manipu-
lation. Allocation to study groups based on ear-tag numbers,
however, can be considered as random because those
numbers are assigned at birth and thus long before the study
and without any fore knowledge of it.
We speculate that the allocation of animals in studies that
claimed to be randomized but did not provide any
information about the method (13·2%) should a priori be
considered as not randomized but as haphazard. However,
missing data, especially regarding older studies, could be
due to incomplete reporting. Therefore, studies with missing
data should not a priori be judged as low quality.
Randomized, controlled clinical trials provide the highest
validity of results obtained (Schulz et al. 1995). However,
this specific study design is not applicable to every question
(Antes, 1998; Smith & Pell, 2003). For example, it might be
unethical to include an untreated control group if that
would inevitably imply serious distress, suffering or even
death for the animals involved (Sayre et al. 2010). The
process of randomization helps to assure that treatment
groups are comparable with respect to known and unknown
factors that could influence the primary outcome variable of
the study (Lund et al. 1994). Our finding that only 38·2% of
the trials were controlled and randomized clearly limits the
strength of evidence of PGF2α as treatment of bovine
endometritis.
Conclusions or treatments inferred from uncontrolled and
unrandomized trials are in general less likely to be true than
those based on randomized controlled trials. In our analysis,
we found a considerable percentage (25·0%) of uncon-
trolled studies that described reproductive performance
Table 6. Reproductive performance parameters described in 68












Calving to first service interval 40·0 33·3
Increase 8·0 33·3
Statistically significant 0·0 0·0
Decrease 16·0 0·0
Statistically significant 8·0 0·0
Calving to conception interval 52·0 33·3
Increase 4·0 0·0
Statistically significant 0·0 0·0
Decrease 24·0 33·3
Statistically significant 12·0 0·0
Conception rate 72·0 33·3
Increase 28·0 0·0
Statistically significant 12·0 0·0
Decrease 8·0 0·0
Statistically significant 0·0 0·0
Table 7. Effects on conception rate after PGF2α treatment described
in trials studying the efficacy of PGF2α treatment of chronically
endometritic cows





6 0 3 3
Positive, authors’ assessment 15 6 5 4
None 9 0 2 7
Negative 7 1 4 2
Total 37 7 14 16
†According to Bassler and Antes (2000)
‡Level 1, i.e. randomized, controlled trials
§Level 2, i.e. well designed, controlled studies without randomization
¶Level 3, i.e. well designed, descriptive non-experimental studies
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parameters. Drawing inference and implementing treatment
decisions based on such results, however, should be
considered carefully. A wide variety of diagnostic methods
were applied in the 68 trials evaluated. It has been
demonstrated that different methods to diagnose endome-
tritis differ in their sensitivity (Drillich et al. 2002; LeBlanc
et al. 2002b).
The classification of cytological endometritis and purulent
vaginal discharge has been most recently described
(Runciman et al. 2008; Dubuc et al. 2010a). Owing to a
shortage of studies based on this new classification, we
decided to use the definition by Sheldon (2006).
Specific and repeatable exclusion criteria were defined to
exclude studies that did not focus on chronic endometritis, i.
e. after 21 d after parturition (Sheldon et al. 2006). Several
studies, however, complied only partly with this time period
and had also enrolled cows earlier, whereas others did not
provide an exact time of diagnosis at all. Therefore we
decided to classify studies according to their time of
diagnosis. This classification was important because several
authors observed a significant self-cure rate in cows with
chronic endometritis during the first weeks post partum. The
self-cure rate ranged from 92% in the first week to 25% in the
seventh week post partum (Falkenberg & Heuwieser, 2005;
Hirsbrunner et al. 2006). A considerable inconsistency
existed also regarding the calculation of the pregnancy
outcome. Some authors assessed overall conception rates,
whereas others calculated a first service conception rate or a
pregnancy rate. Overall, only 19·1% of all studies provided a
concise definition of reproductive performance parameters
used. In addition, a specific definition of endometritis was
not given in 23·5% of all trials analysed. This lack of
homogeneity to some extend limits comparability of study
results.
Our results demonstrate that an impressive percentage of
studies addressing the efficacy of PGF2α are severely flawed
in the study design, and that comparability between
publications is limited owing to considerable differences.
In human medicine intensive examination of the appraising
of available literature has been conducted in the framework
of evidence-based medicine (EBM). However, Arlt &
Heuwieser (2010) point out the need for further appraisal
of scientific publications in veterinary medicine.
One objective of the study was to summarize the effect of
PGF2α for the treatment of endometritis. Of those trials
assessing reproductive performance parameters (calving to
first service interval, calving to conception interval, con-
ception rate), statistically significant effects on reproductive
performance were reported only in a small fraction of trials.
Twenty-two of 37 studies that evaluated conception rate
were attributed to a moderate or high evidence level and did
not show any statistically significant effect of PGF2α
treatment (Table 7). A positive effect was revealed by 21
articles. Of those, only 6 reported a statistical significance.
However, it is stressed by different authors that different
factors, such as the time of diagnosis (LeBlanc et al. 2002b),
the severity of endometritis, or the additional occurrence of
other puerperal disorders (Burton & Lean, 1995) may
influence the efficacy of a PGF2α treatment. Based on our
results, we propose a tendency of low-quality papers
concluding a positive effect without statistical validation
(n=6). However, it is important to emphasize that low-
quality trials do not necessarily show larger effects of a
certain intervention (Kunz & Oxman, 1998). We conclude
that the evidence for the efficacy of PGF2α for the treatment
of chronic bovine endometritis is limited. In combination
with most recent results (Dubuc et al. 2010b), we suggest
that the use of PGF2α as a standard treatment for endometritis
should be critically reconsidered. Further research in the
form of controlled, randomized and blinded trials is required
to assess and quantify the efficacy of this treatment.
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